ArticleBlood2005

Activity of the tyrosine kinase inhibitor PKC412 in a patient with mast cell leukemia with the D816V KIT mutation.

Jason Gotlib et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.